PNC Financial Services Group’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,297
| Closed | -$1.87K | – | 4962 |
|
|
2025
Q1 | $1.87K | Buy |
+1,297
| New | +$1.87K | ﹤0.01% | 4369 |
|
|
2022
Q2 | – | Sell |
-35
| Closed | – | – | 4555 |
|
|
2022
Q1 | $0 | Hold |
35
| – | – | ﹤0.01% | 4567 |
|
|
2021
Q4 | $0 | Hold |
35
| – | – | ﹤0.01% | 4483 |
|
|
2021
Q3 | $0 | Sell |
35
-6
| -15% | – | ﹤0.01% | 4322 |
|
|
2021
Q2 | $1K | Sell |
41
-6,865
| -99% | -$167K | ﹤0.01% | 4105 |
|
|
2021
Q1 | $194K | Buy |
6,906
+6,400
| +1,265% | +$180K | ﹤0.01% | 2179 |
|
|
2020
Q4 | $13K | Hold |
506
| – | – | ﹤0.01% | 3490 |
|
|
2020
Q3 | $19K | Hold |
506
| – | – | ﹤0.01% | 3255 |
|
|
2020
Q2 | $26K | Sell |
506
-1,470
| -74% | -$75.5K | ﹤0.01% | 3089 |
|
|
2020
Q1 | $62K | Buy |
1,976
+1,970
| +32,833% | +$61.8K | ﹤0.01% | 2496 |
|
|
2019
Q4 | $0 | Hold |
6
| – | – | ﹤0.01% | 4017 |
|
|
2019
Q3 | $0 | Hold |
6
| – | – | ﹤0.01% | 4020 |
|
|
2019
Q2 | $0 | Hold |
6
| – | – | ﹤0.01% | 4044 |
|
|
2019
Q1 | $0 | Hold |
6
| – | – | ﹤0.01% | 4051 |
|
|
2018
Q4 | $0 | Hold |
6
| – | – | ﹤0.01% | 4073 |
|
|
2018
Q3 | $0 | Hold |
6
| – | – | ﹤0.01% | 4145 |
|
|
2018
Q2 | $0 | Buy |
+6
| New | – | ﹤0.01% | 4169 |
|
|
2016
Q3 | – | Sell |
-71
| Closed | -$1K | – | 4067 |
|
|
2016
Q2 | $1K | Sell |
71
-3
| -4% | -$42 | ﹤0.01% | 4341 |
|
|
2016
Q1 | $1K | Buy |
74
+3
| +4% | +$41 | ﹤0.01% | 4352 |
|
|
2015
Q4 | $2K | Hold |
71
| – | – | ﹤0.01% | 4151 |
|
|
2015
Q3 | $2K | Buy |
71
+2
| +3% | +$56 | ﹤0.01% | 4273 |
|
|
2015
Q2 | $6K | Buy |
+69
| New | +$6K | ﹤0.01% | 3999 |
|
|
2015
Q1 | – | Sell |
-140
| Closed | -$6K | – | 4708 |
|
|
2014
Q4 | $6K | Hold |
140
| – | – | ﹤0.01% | 3494 |
|
|
2014
Q3 | $3K | Hold |
140
| – | – | ﹤0.01% | 3576 |
|
|
2014
Q2 | $2K | Buy |
+140
| New | +$2K | ﹤0.01% | 3508 |
|